Reliance Life Sciences

Reliance Life Sciences is a research-driven organization dedicated to developing business opportunities in the fields of biotherapeutics (plasma proteins, biosimilars, and novel proteins), pharmaceuticals (late-stage, oncology generics), clinical research services, regenerative medicine (stem cell therapy), and molecular medicine. Reliance Life Sciences launched five of the world’s first biosimilars, possesses the largest number of biosimilars in the Indian market, and has developed the highest number of biosimilars globally. It is distinguished as South Asia's first integrated manufacturer of plasma proteins. Reliance Life Sciences has catalyzed the rise of regenerative medicine in the country and holds the most extensive Indian experience in umbilical cord blood stem cell transplantation. RLS is one of the few centers worldwide offering specialized testing in molecular medicine and molecular genetics.